CLEAN : Ebola vaccine trials begin in Switzerland 2

The video discusses a trial involving 400 volunteers, with 120 selected for participation. Of these, 50 will go to West Africa, and 70 will stay in Switzerland. The trial is deemed safe for both volunteers and those handling biological samples. The speaker expresses personal motivation to help expedite vaccine development, despite not being able to conduct research directly.

How many volunteers expressed interest in participating in the trial?

• 200

• 300

• 400

• 500

How many volunteers will potentially be sent to West Africa?

• 30

• 40

• 60

• 50

What is emphasized about the safety of the trial?

• It is safe only for the volunteers.

• It is safe for both volunteers and those handling samples.

• It is safe only for the researchers.

• It is not safe for anyone involved.

What motivates the speaker to participate in the trial?

• To travel to West Africa

• To conduct research directly

• To gain personal recognition

• To help expedite the vaccine development

What does the speaker feel about their participation in the trial?

• Anxious

• Proud

• Regretful

• Indifferent